Drawing for EMBOZENE TANDEM

USPTO serial 85395551

EMBOZENE TANDEM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
CORDOVA, RAUL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMBOZENE TANDEM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 Thomas Jefferson St., NWSuite 400WASHINGTON, DC 20007

Goods and services

ClassDescriptionStatusFirst use
010Medical devices for embolization, namely, syringes and vials filled with embolic microspheres for embolization; Medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; Medical devices for embolization, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; Medical devices for embolization, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical devices for embolization, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical devices for embolization, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical devices for embolization, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical microspheres for transarterial embolization of tumors, chemoembolization, transarterial chemoembolization, lesion devascularization, lobe devascularization, and proximal embolization; Medical microspheres for the treatment of hypervascular tumors and arteriovenous malformations; Medical microspheres for super selective, targeted chemoembolization of a hypervascular tissue or tumor; Drug delivery device, namely a drug delivery microsphere for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment; Drug delivery device, namely a drug delivery bead for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatmentACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 6, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 6, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 3, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 2, 2014EX5GSOU EXTENSION 5 GRANTED
Aug 25, 2014EXT5SOU EXTENSION 5 FILED
Aug 25, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 13, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 12, 2014EX4GSOU EXTENSION 4 GRANTED
Feb 28, 2014EXT4SOU EXTENSION 4 FILED
Feb 28, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 7, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 6, 2013EX3GSOU EXTENSION 3 GRANTED
Aug 28, 2013EXT3SOU EXTENSION 3 FILED
Aug 28, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 30, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 15, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 14, 2013EX2GSOU EXTENSION 2 GRANTED
Mar 14, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 28, 2013EXT2SOU EXTENSION 2 FILED
Feb 28, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 30, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2012EX1GSOU EXTENSION 1 GRANTED
Aug 28, 2012EXT1SOU EXTENSION 1 FILED
Aug 28, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 10, 2012DOCKASSIGNED TO EXAMINER
Feb 28, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 3, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 3, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 14, 2011NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 25, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2011DOCKASSIGNED TO EXAMINER
Aug 16, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2011NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance